VYNE Therapeutics Statistics
Total Valuation
VYNE has a market cap or net worth of $34.82 million. The enterprise value is -$58.27 million.
| Market Cap | 34.82M |
| Enterprise Value | -58.27M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VYNE has 14.10 million shares outstanding. The number of shares has increased by 222.44% in one year.
| Shares Outstanding | 14.10M |
| Shares Change (YoY) | +222.44% |
| Shares Change (QoQ) | +213.01% |
| Owned by Insiders (%) | 8.69% |
| Owned by Institutions (%) | 59.21% |
| Float | 9.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 82.13 |
| Forward PS | 75.87 |
| PB Ratio | 0.39 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.73, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.73 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -79.10% and return on invested capital (ROIC) is -32.89%.
| Return on Equity (ROE) | -79.10% |
| Return on Assets (ROA) | -64.20% |
| Return on Capital (ROIC) | -32.89% |
| Revenue Per Employee | $42,400 |
| Profits Per Employee | -$2.85M |
| Employee Count | 10 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.74% in the last 52 weeks. The beta is 1.46, so VYNE's price volatility has been higher than the market average.
| Beta (1Y) | 1.46 |
| 52-Week Price Change | -44.74% |
| 50-Day Moving Average | 2.43 |
| 200-Day Moving Average | 3.14 |
| Relative Strength Index (RSI) | 48.41 |
| Average Volume (30 Days) | 108,862 |
Short Selling Information
The latest short interest is 96,825, so 0.69% of the outstanding shares have been sold short.
| Short Interest | 96,825 |
| Short Previous Month | 85,622 |
| Short % of Shares Out | 0.69% |
| Short % of Float | 1.02% |
| Short Ratio (days to cover) | 0.59 |
Income Statement
In the last 12 months, VYNE had revenue of $424,000 and -$28.45 million in losses. Loss per share was -$2.78.
| Revenue | 424,000 |
| Gross Profit | 424,000 |
| Operating Income | -29.26M |
| Pretax Income | -28.45M |
| Net Income | -28.45M |
| EBITDA | -28.45M |
| EBIT | -28.45M |
| Loss Per Share | -$2.78 |
Balance Sheet
The company has $93.31 million in cash and $214,000 in debt, giving a net cash position of $93.09 million or $6.60 per share.
| Cash & Cash Equivalents | 93.31M |
| Total Debt | 214,000 |
| Net Cash | 93.09M |
| Net Cash Per Share | $6.60 |
| Equity / Book Value | 88.74M |
| Book Value Per Share | 6.29 |
| Working Capital | 88.43M |
Cash Flow
| Operating Cash Flow | -25.34M |
| Capital Expenditures | n/a |
| Free Cash Flow | -25.34M |
| FCF Per Share | -$2.47 |
Margins
Gross margin is 100.00%, with operating and profit margins of -6,900.47% and -6,710.38%.
| Gross Margin | 100.00% |
| Operating Margin | -6,900.47% |
| Pretax Margin | -6,710.38% |
| Profit Margin | -6,710.38% |
| EBITDA Margin | -6,710.38% |
| EBIT Margin | -6,710.38% |
| FCF Margin | -5,976.65% |
Dividends & Yields
VYNE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -222.44% |
| Shareholder Yield | -222.44% |
| Earnings Yield | -81.70% |
| FCF Yield | -72.77% |
Analyst Forecast
The average price target for VYNE is $7.38, which is 198.79% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.38 |
| Price Target Difference | 198.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 167.61% |
| EPS Growth Forecast (5Y) | -44.01% |
Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:18.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:18 |
Scores
VYNE has an Altman Z-Score of -7.44 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.44 |
| Piotroski F-Score | 3 |